This double-blind randomized clinical trial study designed to evaluate tranexamic acid efficacy on upper gastrointestinal bleeding management. Eligible patients (age more than 18 years old and accept to contribute in the study, as well as no contraindication for tranexamic acid) after initial resuscitation will divide to two groups: 1.intervention group: further standard treatment of gastrointestinal treatment, these patients will receive 1 gr intravenous tranexamic acid in 10 minutes , as well as another same dose in next 8 hours; 2.control group: further standard treatment of gastrointestinal treatment, these patients will receive placebo. Initial evaluation of patients will perform by upper gastrointestinal endoscopy, and then patients will check for needs for emergent endoscopy or surgery, rebleeding, need for blood transfusion and death related to gastrointestinal bleeding. Finally all data will analyze for evaluation of tranexamic acid effect on upper gastrointestinal bleeding outcomes.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2014112911956N4
Registration date:2014-12-19, 1393/09/28
Registration timing:prospective
Last update:
Update count:0
Registration date
2014-12-19, 1393/09/28
Registrant information
Name
Morteza Talebi Doluee
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3852 5312
Email address
talebidm@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Dr. Mohsen Tafaghodi, Educational Assistance, Mashhad University of Medical Sciences
Expected recruitment start date
2015-01-21, 1393/11/01
Expected recruitment end date
2015-05-22, 1394/03/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of Tranexamic acid effect on upper gastrointestinal bleeding outcomes
Public title
Tranexamic acid efficacy in reduction of upper gastointestinal bleeding complications
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: All patients with signs and symptoms of upper gastrointestinal bleeding, which will present to emergency ward and have all of these conditions: age more than 18 years old and hemodynamically stable condition(systolic blood pressure more than 90 mmHg and pulse rate less than 110 bpm), as well as accept to contribute in the study(by consent form).
Exclusion criteria: age less than 18 years old; pregnancy and breast feeding; Tranexamic Acid contraindications: history of thromboembolic disorders, nephrotic syndrome, current estrogen consumption, history of allergy to tranexamic acid or variceal hemorrhage; patients that need to anticoagulant therapy; probable DIC; history of epilepsy or brain disorders; cancer ( except for who has been treated and no recurrence has occurred in one years ago).
Age
No age limit
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
100
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Mashhad University of Medical Sciences
Street address
Mashhad, Shahid Fakoori blvd, Health and Knowledge town, Zakaria building, First floor, Postal code: 345
City
Mashhad
Postal code
9177899191
Approval date
2014-07-26, 1393/05/04
Ethics committee reference number
930035
Health conditions studied
1
Description of health condition studied
Upper gastrointestinal haemorrhage
ICD-10 code
K92.0
ICD-10 code description
Haematemesis
Primary outcomes
1
Description
Decrease in mortality of upper gastrointestinal bleeding
Timepoint
one week
Method of measurement
Questionnaire
Secondary outcomes
1
Description
decrease in rebleeding
Timepoint
24 houres
Method of measurement
Questionnaire
2
Description
decrease in need to endoscopic treatment
Timepoint
24 houres
Method of measurement
Questionnaire
3
Description
decrease in need to blood component transfusion
Timepoint
first week
Method of measurement
Questionnaire
Intervention groups
1
Description
Intervention group: after standard treatment of upper GI bleeding, these patients would receive intravenously 1 gr tranexamic acid (100 and 250 mg vials are available) in 10 minutes, then 1 gr tranexamic acid will prescribe slow intravenously in next 8 houres.
Category
Treatment - Drugs
2
Description
Control group: after standard treatment of upper GI bleeding, these patients would receive normal saline as placebo, as same the intervention group, first in a vial in 10 minutes and then slow intravenously in next 8 houres.
Category
Behavior
Recruitment centers
1
Recruitment center
Name of recruitment center
Emam Reza Educational, Research and Treatment Center
Full name of responsible person
Sanaz Javdani Masroor Tanha
Street address
Emam Reza Square, Ebne Sina Avenue, Mashhad
City
Mashhad
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Dr. Mohsen Tafaghodi
Street address
Ghoreyshi Building, Daneshgah Strees, Mashhad
City
Mashhad
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Sanaz Javdani Masroor Tanha
Position
MD, Emegency Medicine assistant
Other areas of specialty/work
Street address
Emam Reza Hospital, Emam Reza Square, Ebne Sina Avenue.
City
Mashhad
Postal code
Phone
+98 51 3854 3031
Fax
Email
javedanis921@mums.ac.ir
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Dr. Morteza Talebi Doluee
Position
Assistant professor of Emergency Medicine
Other areas of specialty/work
Street address
Emam Reza Hospital-Emam Reza Square, Ebne Sina Avenue.
City
Mashhad
Postal code
00989137913316
Phone
+98 51385430319
Fax
Email
talebidm@mums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Sanaz Javdani Masroor Tanha
Position
MD, Emergency Medicine assistant
Other areas of specialty/work
Street address
Azadi Square, Pardis Campus.
City
Mashhad
Postal code
917794 8564
Phone
+98 51 3882 8888
Fax
Email
javedanis921@mums.ac.ir
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)